Stem Cell Clinics throughout the U.S. promote stem cell therapy for a variety of health conditions including osteoarthritis, autism, macular degeneration, Parkinson’s Disease, Alzheimer’s Disease and most recently COVID-19 infections. How can our patients be assured that the regenerative medicine therapy effectively treats their health condition and the products they receive are safe? In this podcast, we discuss regulations regarding regenerative medicine, the process of obtaining FDA-approval and which regenerative medicine therapies are FDA-approved. Our guest will be Drew Witter, a Program Manager from the Office of Research and Regulatory Support at the Mayo Clinic.
Watch the full video at watch.giblib.c...
Check out other videos in this conference at watch.giblib.c...
Interested in CME? Conveniently earn unlimited AMA PRA Category 1 Credit(s)™ by subscribing to GIBLIB’s premium plan.
GIBLIB is increasing access to credible medical updates and the highest quality medical education by partnering with the best in medicine, such as Mayo Clinic, University of California San Francisco, Cleveland Clinic, Cedars-Sinai Medical Center, Hospital for Special Surgery, Stanford Children’s Hospital and more.
Learn more about GIBLIB at www.giblib.com/
Visit our blog at www.giblib.com...
⟡ Follow Us ⟡
Instagram: / giblib
Facebook: / thegiblibapp
Twitter: / thegiblibapp
LinkedIn: / giblib
#FDA #mayoclinic #regenerativemedicine
Негізгі бет Regenerative Medicine: FDA Regulatory Process and Clinical Trials | Conference Preview
Пікірлер